The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Global analysis of death rates among women living with HIV during the first four years of antiretroviral treatment (ART) finds most deaths occur within three months – with some distinct regional variations.
To what extent do existing policies relating to age of consent for sexual reproductive health (SRH) services also affect PrEP access?
New technical guidance from the World Health Organization recognises effectiveness of event-driven PrEP for gay men following Prevenir study results.
An Avert spotlight on the HIV response – we reflect on the most important take-homes from the UNAIDS 2019 Global Report.
New study finds treatment adherence a major challenge for excluded and hard to reach populations living with HIV, exacerbating existing health inequalities.
Two out of seven mice who received novel treatment and gene editing technology have had HIV eliminated from their bodies, reveals a ground-breaking study.
"I'm still to find those people who identify as British or maybe Asian, south Asian that are open about their HIV status because it is so stigmatised."
Failure to diagnose and late-presenters to care continue to contribute to cryptococcal-related mortality in people living with HIV in low-resourced contexts.
PARTNER2 trial results confirm that gay men can also benefit from U=U (undetectable=untransmittable), as Lancet publishes final study report.
In the latest in our new series of guest blogs from citizen journalists in southern Africa, Denver Kisting talks to lawyer Arvind Narrain about his early days of LGBT campaigning and where we’re at with decriminalising homosexuality.